These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 322860)

  • 21. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
    Günther JH; Frambach M; Deinert I; Brandau S; Jocham D; Böhle A
    J Urol; 1999 May; 161(5):1702-6. PubMed ID: 10210443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M; Kimoto M; Suzuki I; Nomoto K
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
    Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
    Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
    Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
    Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirements for CD4(+) T cell levels in acute Mycobacterium bovis strain bacille Calmette Guerin (BCG)-induced granulomas differ for optimal mycobacterial control versus granuloma formation.
    Hogan LH; Heninger E; Elsner RA; Vonderheid HA; Hulseberg P; Co D; Sandor M
    Int Immunol; 2007 May; 19(5):627-33. PubMed ID: 17446212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
    Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
    J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
    Senaldi G; Shaklee CL; Mak TW; Ulich TR
    Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unanticipated effect of BCG in mice treated by radiotherapy.
    Serrou B; Dubois JB
    Dev Biol Stand; 1977 Apr 13-15; 38():369-72. PubMed ID: 344099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of IFN-gamma in Bacillus Calmette-Guérin-induced but not in tumor-induced sensitization to TNF-induced lethality.
    Cauwels A; Brouckaert P; Grooten J; Huang S; Aguet M; Fiers W
    J Immunol; 1995 Mar; 154(6):2753-63. PubMed ID: 7876546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA; Chin JL; Batislam E; Karlik SJ; Garcia B; Skamene E
    J Urol; 1997 Aug; 158(2):646-52. PubMed ID: 9224385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent adjuvant effects of Bacillus Calmette-Guérin on tumor immunity in Lewis rats.
    Davies M; Sabbadini E
    Cancer Res; 1979 Mar; 39(3):959-65. PubMed ID: 311684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic and cytokinetic parameters of BCG-induced growth control of a murine leukemia.
    Olsson L
    Recent Results Cancer Res; 1977; (62):28-35. PubMed ID: 601336
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 37. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Bartlett GL; Purnell DM; Kreider JW
    Science; 1976 Jan; 191(4224):299-301. PubMed ID: 1108198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modifications by BCG of the mortality of the irradiated mouse].
    Allain P; Chaleil D; Maingot D; Larra F
    C R Seances Soc Biol Fil; 1976; 170(1):31-6. PubMed ID: 134782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy with neuraminidase-treated cells and bacillus Calmette-Guerin.
    Kollmorgen GM; Killion JJ; Sansing WA; Cantrell JL; Bundren JC; LeFever AV
    Surgery; 1976 Feb; 79(02):202-8. PubMed ID: 1108258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria.
    Lamensans A; Chedid L; Lederer E; Rosselet JP; Gustafson RH; Spencer HJ; Ludwig B; Berger FM
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3656-60. PubMed ID: 171670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.